Advisory Board
Fulvio Mavilio, PhD
CSO at Orchard Therapeutics
35y experience in gene therapy. Scientific leader in translational medicine and vector development for rare diseases.
Julian Hanack
CEO & Chief Dev. Officer
Experienced biotech CEO with a strong track record in gene therapy. CEO at Purespring Therapeutics, pioneering AAV-based treatments for kidney diseases.
Andrea Truini, MD, PhD
Neurologist
Neurologist with clinical focus on peripheral nerve diseases and chronic pain. Scientific work fully dedicated to neuropathic pain and human nociceptive system diagnostics.